-+ 0.00%
-+ 0.00%
-+ 0.00%
Tdspharm Corrects Independent Director Change Date to Nov. 23, 2026
Share
Listen to the news
Tdspharm Corrects Independent Director Change Date to Nov. 23, 2026
  • Tdspharm corrected the independent director change date to Nov. 23, 2026, from Nov. 24 in its Nov. 18 filing.
  • Total registered directors before and after the change were revised to three from two; independent representation remains one director, or 33.3%.
  • The newly appointed independent director’s three-year term begins Nov. 24, 2026, following the incumbent’s term expiration on Nov. 23.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tdspharm Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261118000115), on November 18, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending